- Home
- INM vs CNSP Comparison
INM vs CNSP Comparison
Compare INM & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INM
- CNSP
- Stock Information
- Founded
- INM 1981
- CNSP 2017
- Country
- INM Canada
- CNSP United States
- Employees
- INM N/A
- CNSP N/A
- Industry
- INM Biotechnology: Pharmaceutical Preparations
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- INM Health Care
- CNSP Health Care
- Exchange
- INM Nasdaq
- CNSP Nasdaq
- Market Cap
- INM 4.3M
- CNSP 4.0M
- IPO Year
- INM N/A
- CNSP 2019
- Fundamental
- Price
- INM $2.28
- CNSP $10.26
- Analyst Decision
- INM
- CNSP Strong Buy
- Analyst Count
- INM 0
- CNSP 1
- Target Price
- INM N/A
- CNSP $20.00
- AVG Volume (30 Days)
- INM 93.9K
- CNSP 50.6K
- Earning Date
- INM 11-13-2025
- CNSP 11-14-2025
- Dividend Yield
- INM N/A
- CNSP N/A
- EPS Growth
- INM N/A
- CNSP N/A
- EPS
- INM N/A
- CNSP N/A
- Revenue
- INM $4,942,633.00
- CNSP N/A
- Revenue This Year
- INM N/A
- CNSP N/A
- Revenue Next Year
- INM N/A
- CNSP N/A
- P/E Ratio
- INM N/A
- CNSP N/A
- Revenue Growth
- INM 7.50
- CNSP N/A
- 52 Week Low
- INM $1.72
- CNSP $4.93
- 52 Week High
- INM $8.27
- CNSP $221.94
- Technical
- Relative Strength Index (RSI)
- INM 49.66
- CNSP 69.30
- Support Level
- INM $2.17
- CNSP $8.50
- Resistance Level
- INM $2.30
- CNSP $9.24
- Average True Range (ATR)
- INM 0.12
- CNSP 0.49
- MACD
- INM 0.01
- CNSP 0.01
- Stochastic Oscillator
- INM 41.16
- CNSP 94.44
About INM InMed Pharmaceuticals Inc.
InMed Pharmaceuticals Inc is a Canada based clinical-stage biopharmaceutical company. The company is engaged in the research and development of novel, cannabinoid-based, and manufacturing of Pharmaceutical grade cannabinoids. Its product portfolio includes INM-755, which is used for the treatment of epidermolysis bullosa; INM-088 for the treatment of glaucoma; INM-901 for Alzheimer's disease, INM-089's pharmacological and IntegraSyn which is a manufacturing system for Pharmaceutical-Grade Cannabinoids.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.